rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    XGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Exagen director Jorey Chernett sells $745,794 in XGN shares
      Nov 14Investing.comXGN
      Exagen: Q3 Raises Questions About The Turnaround (Rating Downgrade)

      Analyst rates Exagen (XGN) stock a Hold, as Q3 revenue grew 7% year over year but fell 8% sequentially.

      Nov 13Seeking AlphaXGN
      Exagen director Jorey Chernett buys $372,977 in shares
      Nov 12Investing.comXGN
      Exagen Inc (XGN) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue, 14th Straight ASP Gain, ...

      Exagen Inc (XGN) posted its best-ever third quarter with $18.4 million in revenue, record $451 ASP, and 85% Pharma Services growth, while teeing up its highly anticipated myositis test for early 2027.

      Nov 11Yahoo FinanceXGN
      What Exagen (XGN) Said on Its Q3 Earnings Call
      Nov 10Yahoo FinanceXGN
      Exagen Q3 2026 Earnings Call Transcript
      Nov 10BenzingaXGN
      Earnings call transcript: Exagen’s Q3 2026 revenue edges past forecasts as shares fall
      Nov 10Investing.comXGN
      Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates
      Nov 10Yahoo FinanceXGN
      Exagen Inc. Reports Third Quarter 2026 Financial Results
      Nov 10Yahoo FinanceXGN
      Exagen to Announce Third Quarter Financial Results on November 10, 2026
      Oct 27Yahoo FinanceXGN
      Exagen director Jorey Chernett buys $104,440 in XGN stock
      Oct 20Investing.comXGN
      Exagen president and CEO John Aballi sells $269,790 in shares
      Oct 20Investing.comXGN
      Exagen Insider Sold Shares Worth $269,791, According to a Recent SEC Filing
      Oct 19Yahoo FinanceXGN
      Exagen (XGN) Receives a Buy from Roth MKM

      Detailed price information for Exagen Inc (XGN-Q) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailXGN
      Full Transcript: Exagen Q2 2026 Earnings Call
      Sep 17BenzingaXGN

      This is the newest page. Registered accounts read further back.